An independent prospective randomised controlled trial comparing the efficacy and cost effectiveness of infliximab and etanercept in 'high need' patients with moderate to severe chronic plaque type psoriasis.

Trial Profile

An independent prospective randomised controlled trial comparing the efficacy and cost effectiveness of infliximab and etanercept in 'high need' patients with moderate to severe chronic plaque type psoriasis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2016

At a glance

  • Drugs Etanercept (Primary) ; Infliximab (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Acronyms PIECE
  • Most Recent Events

    • 15 Jul 2016 Results published in the British Journal of Dermatology
    • 15 Jul 2016 Status changed from recruiting to completed, as per the results published in the British Journal of Dermatology.
    • 17 May 2009 Status changed from planning to recruiting as reported by Netherlands Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top